CA209-9MJ: Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy (clinicaltrials.gov) - Sep 17, 2026 - P1/2 | N=44 | Completed | Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Trial completion date: Dec 2026 ➔ Jun 2026 | Active, not recruiting ➔ Completed
Trial completion • Trial completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor • Urology
|